Provide support for the rapidly growing field of synthetic biology.
According to foreign media reports , Evonetix focusing on DNA synthesis technology a> The company announced the completion of a $ 30 million Series B financing. This round of funds will be used to accelerate the development of internal technologies, including integrating Evonetix’s technology to achieve DNA synthesis on a chip, and introducing a desktop DNA synthesis platform and applying it to Healthcare, medicine and biotechnology.
Evonetix was founded in 2016 and is headquartered in Cambridge, England. It aims to develop technology that can synthesize DNA in parallel on silicon well plate arrays to promote the rapid development of synthetic biology and cope with high throughput and high precision DNA. The demand for synthesis is increasing. Previously, Evonetix has completed $ 12.3 million A round of financing < / a>.
Specifically, Evonetix’s technology platform utilizes micro-electro-mechanical systems (MEMS) -processed silicon chips in a highly parallel manner at thousands of independently controlled reaction sites or “pixels” on the surface of the chip The synthesis of DNA is controlled here. After synthesis, the synthesized DNA strands are assembled into double strands on a silicon wafer. This process finds and eliminates errors in synthesis in order to achieve large-scale, integrated automation, and high-fidelity synthesis of the produced DNA, which is superior in scale and speed to traditional methods.
In addition, This DNA synthesis method can also synthesize “difficult” sequences, such as GC-enriched sequences or repeated sequences.
Extensible and controllable DNA synthesis (left) + integrated automated error checking (right) (Image source: Evonetix official website)
It is reported that this technical method includes two key components: 1) Highly scalable DNA synthesis platform with precise control of synthesis loop nodes Modules; 2) The ability to integrate automated error checking during the synthesis process to ensure high-fidelity production of DNA molecules.
Not long ago, Evonetix teamed up with Imec, a player that is very active in nanoelectronics and digital technology, which is seeking to increase the production of its proprietary microelectromechanical systems (MEMS) -based silicon This platform can realize large-scale manufacturing. This silicon chip is a key component of the Evonetix desktop DNA platform, which, once fully developed, will support the rapidly growing field of synthetic biology.
Industry pointed out , synthetic biology It will become the focus of the next round of change in the life sciences field, which may provide new opportunities to fundamentally change the way of managing the earth’s resources, but this process also requires large-scale and high-precision DNA synthesis. Evonetix provides a Produce a solution for DNA synthesis.